OLFM4 Antibodies
Target Information
May promote proliferation of pancreatic cancer cells by favoring the transition from the S to G2/M phase. In myeloid leukemic cell lines, inhibits cell growth and induces cell differentiation and apoptosis. May play a role in the inhibition of EIF4EBP1 phosphorylation/deactivation. Facilitates cell adhesion, most probably through interaction with cell surface lectins and cadherin. Expressed during myeloid lineage development. Much higher expression in bone marrow neutrophils than in peripheral blood neutrophils (at protein level). Strongly expressed in the prostate, small intestine and colon and moderately expressed in the bone marrow and stomach. Overexpressed in some pancreatic cancer tissues. Note: This description may include information from UniProtKB.
Alternate Names
Antiapoptotic protein GW112; bA209J19.1; G-CSF-stimulated clone 1 protein; GC1; Gm296; Gm913; GW112; hGC-1; hOLfD; KIAA4294; olfactomedin 4; Olfactomedin-4; OlfD; OLFM4; Olfm4; OLM4; pPD4; PU.1 difference product 4; UNQ362OLFM4 Antibody Products
4 Products- 25426WBIHCIFMRecombinant Monoclonal
Why CST
Cell Signaling Technology is trusted by the global scientific research community. Our highly cited antibodies offer unrivaled specificity and reproducibility. Learn more about why researchers choose CST:
Contact
Don’t see an antibody for your specific needs? Browse more products, learn more about our services or get in touch with us: